Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Afatinib in Head and Neck Cancer
NCT01538381Phase 2Completed
- Sponsor
- European Organisation for Research and Treatment of Cancer
- Start
- Jul 2012
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of afatinib in squamous cell carcinoma of the head and neck (HNSCC), sponsored by European Organisation for Research and Treatment of Cancer. Started Jul 2012; status: completed.
02
Drugs
afatinib
03
Conditions
squamous cell carcinoma of the head and neck (HNSCC)
Beyond the preview
Go deeper on NCT01538381.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01538381.